!nkA project for more inclusion traineeships successfully completed
The Paul-Ehrlich-Institut (PEI), the Federal Institute for Vaccines and Biomedicines, is committed to the professional integration of disabled people in many ways. On 13 September 2018, the inclusion project !nkA coordinated by Annetraud Grote from PEI was successfully finalized in Berlin.
CAR T cells generated in vivo
In August 2018, two CAR T cell therapeutics obtained marketing authorization from the European Commission. They provide efficacious treatment options for patients suffering from certain forms of leukemia and who have not responded to other treatment options. However, manufacturing CAR T cells that are composed of genetically engineered patient immune cells is laborious: the cells are taken from the patient, genetically modified with the CAR, multiplied and then reinfused into the same patient.
Paul-Ehrlich-Institut supports blood donation facilities with new online database
As of today, 3 September 2018, the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, provides an online database for blood donation facilities. The database offers access to information on worldwide occurrences of infections with certain pathogen which are relevant for the safety of blood donation.